{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:05:08Z","timestamp":1789517108119,"version":"build-2803163510"},"reference-count":116,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK095424"],"award-info":[{"award-number":["DK095424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK062294"],"award-info":[{"award-number":["DK062294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK089206"],"award-info":[{"award-number":["DK089206"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK101442"],"award-info":[{"award-number":["DK101442"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK118528"],"award-info":[{"award-number":["DK118528"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK136617"],"award-info":[{"award-number":["DK136617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gestational diabetes mellitus (GDM), defined as glucose intolerance that starts during pregnancy, represents a major public health challenge because it is a major cause of adverse maternal and fetal outcomes and presents a significantly high risk of diabetes, obesity, and cardiovascular disease for both the mother and the infant.<\/jats:p>\n                  <jats:p>The diagnosis of GDM is currently made through oral glucose tolerance tests (OGTT); other markers of glycemic control have notably failed for GDM diagnosis. Since the treatment of GDM reduces the incidence of adverse pregnancy outcomes, screening for GDM with OGTTs in pregnancy weeks 24 to 28 is the standard of care in most nations worldwide. However, universal screening is difficult to achieve due, in part, to the fact that OGTTs are cumbersome and uncomfortable.<\/jats:p>\n                  <jats:p>Thus, the importance of detecting glucose intolerance in pregnant women, the possibility of reducing with treatment the associated risks, the low sensitivity of glycemic markers in pregnancy, and the multiple problems associated with OGTTs highlight the significance of exploring alternative screening\/diagnostic methods that are sensitive, accurate, and well-tolerated by patients.<\/jats:p>\n                  <jats:p>In this review, we summarize our discovery, development, and clinical validation in six human studies of plasma glycated CD59 (pGCD59), the glucose-modified form of the key complement inhibitor CD59, as a biomarker for screening, diagnosis, and monitoring of GDM.<\/jats:p>","DOI":"10.1210\/endrev\/bnag010","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:24:54Z","timestamp":1776684294000},"page":"565-576","source":"Crossref","is-referenced-by-count":1,"title":["Glycated CD59: a novel biomarker for gestational diabetes"],"prefix":"10.1210","volume":"47","author":[{"given":"Michelle","family":"Toth Castillo","sequence":"first","affiliation":[{"name":"Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shauntina","family":"Drayton Powell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Biermann","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Torrey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-5164","authenticated-orcid":false,"given":"Miguel Angel","family":"Luque-Fernandez","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Granada , Granada ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4749-5285","authenticated-orcid":false,"given":"Jose","family":"Halperin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"10397","key":"2026091519562313100_bnag010-B1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"2026091519562313100_bnag010-B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the U.S. in 2022","volume":"47","author":"Parker","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"2026091519562313100_bnag010-B3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","article-title":"Gestational diabetes mellitus","volume":"5","author":"McIntyre","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2026091519562313100_bnag010-B4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/AOG.0000000000002726","article-title":"Research gaps in gestational diabetes mellitus: executive summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop","volume":"132","author":"Wexler","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2026091519562313100_bnag010-B5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/dme.12381","article-title":"Trying to understand gestational diabetes","volume":"31","author":"Catalano","year":"2014","journal-title":"Diabet Med"},{"issue":"4 Pt 1","key":"2026091519562313100_bnag010-B6","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9378(91)90438-W","article-title":"Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes","volume":"165","author":"Catalano","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2026091519562313100_bnag010-B7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc18-1646","article-title":"Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes and childhood glucose metabolism","volume":"42","author":"Lowe","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"2026091519562313100_bnag010-B8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/dc18-2021","article-title":"Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal glycemia and childhood glucose metabolism","volume":"42","author":"Scholtens","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"2026091519562313100_bnag010-B9","first-page":"1","article-title":"NIH consensus development conference: diagnosing gestational diabetes mellitus","volume":"29","author":"Vandorsten","year":"2013","journal-title":"NIH Consens State Sci Statements"},{"issue":"14","key":"2026091519562313100_bnag010-B10","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","article-title":"A multicenter, randomized trial of treatment for mild gestational diabetes","volume":"361","author":"Landon","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"2026091519562313100_bnag010-B11","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa042973","article-title":"Effect of treatment of gestational diabetes mellitus on pregnancy outcomes","volume":"352","author":"Crowther","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"2026091519562313100_bnag010-B12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/AOG.0000000000002498","article-title":"ACOG Practice Bulletin No. 190 summary: gestational diabetes mellitus","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2026091519562313100_bnag010-B13","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.2337\/dc10-0719","article-title":"International Association of Diabetes and Pregnancy study groups, recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care March"},{"key":"2026091519562313100_bnag010-B14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.diabres.2014.02.012","article-title":"Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a world health organization guideline","volume":"103","author":"Agarwal","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2026091519562313100_bnag010-B15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diabres.2003.08.005","article-title":"Gestational diabetes: problems associated with the oral glucose tolerance test","volume":"63","author":"Agarwal","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 1","key":"2026091519562313100_bnag010-B16","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc09-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"32","author":"American Diabetes Association","year":"2009","journal-title":"Diabetes Care"},{"issue":"16","key":"2026091519562313100_bnag010-B17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198610163151603","article-title":"Relation of glucose tolerance to complications of pregnancy in nondiabetic women","volume":"315","author":"Tallarigo","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"2026091519562313100_bnag010-B18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0002-9378(87)80045-5","article-title":"The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy","volume":"157","author":"Langer","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2026091519562313100_bnag010-B19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0002-9378(95)90183-3","article-title":"Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto tri-hospital gestational diabetes project","volume":"173","author":"Sermer","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2026091519562313100_bnag010-B20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0020-7292(97)00221-X","article-title":"Gestational diabetes mellitus and glucose intolerance in a Mexican population","volume":"59","author":"Forsbach","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2026091519562313100_bnag010-B21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mob.2001.108085","article-title":"Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden","volume":"184","author":"Aberg","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2026091519562313100_bnag010-B22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mob.2001.115864","article-title":"Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus","volume":"185","author":"Jensen","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"1 Suppl 1","key":"2026091519562313100_bnag010-B23","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"16","key":"2026091519562313100_bnag010-B24","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.21037\/atm-20-5464","article-title":"The diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus among Chinese pregnant individuals","volume":"8","author":"Lai","year":"2020","journal-title":"Ann Transl Med"},{"issue":"5","key":"2026091519562313100_bnag010-B25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9378(84)90420-4","article-title":"Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy","volume":"150","author":"Cousins","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2026091519562313100_bnag010-B26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1464-5491.2002.00684.x","article-title":"Screening for gestational diabetes; past, present and future","volume":"19","author":"Hanna","year":"2002","journal-title":"Diabet Med"},{"issue":"8","key":"2026091519562313100_bnag010-B27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2337\/diacare.13.8.872","article-title":"Total serum glycosylated proteins in detection and monitoring of gestational diabetes","volume":"13","author":"Cefalu","year":"1990","journal-title":"Diabetes Care"},{"issue":"1","key":"2026091519562313100_bnag010-B28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0020-7292(91)90534-C","article-title":"Fructosamine as a screening-test for gestational diabetes mellitus: a reappraisal","volume":"34","author":"Nasrat","year":"1991","journal-title":"Int J Gynaecol Obstet"},{"issue":"7","key":"2026091519562313100_bnag010-B29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3390\/jcm10071533","article-title":"Emerging protein biomarkers for the diagnosis or prediction of gestational diabetes-a scoping review","volume":"10","author":"Bogdanet","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"2026091519562313100_bnag010-B30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13098-023-00980-8","article-title":"Biochemical and molecular biomarkers: unraveling their role in gestational diabetes mellitus","volume":"15","author":"Karami","year":"2023","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"2026091519562313100_bnag010-B31","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/jog.13317","article-title":"Plasma microRNA-16-5p, -17-5p and -20a-5p: novel diagnostic biomarkers for gestational diabetes mellitus","volume":"43","author":"Cao","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"2026091519562313100_bnag010-B32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12967-023-04269-2","article-title":"Exploring the potential of microRNA as a diagnostic tool for gestational diabetes","volume":"21","author":"Elhag","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"2026091519562313100_bnag010-B33","doi-asserted-by":"crossref","first-page":"bvae207","DOI":"10.1210\/jendso\/bvae207","article-title":"Relationship between 1,5 anhydroglucitol, glycemia, and breastfeeding during pregnancy and postpartum: a pilot study","volume":"9","author":"Soffer","year":"2024","journal-title":"J Endocr Soc"},{"issue":"3","key":"2026091519562313100_bnag010-B34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000318705","article-title":"Gestational diabetes: an evaluation of serum fructosamine as a screening test in a high-risk population","volume":"71","author":"Agarwal","year":"2011","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"2026091519562313100_bnag010-B35","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2337\/diacare.27.5.1200","article-title":"Hba1c levels are significantly lower in early and late pregnancy","volume":"27","author":"Nielsen","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"2026091519562313100_bnag010-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.1997.d01-890.x","article-title":"Extrahepatic complement biosynthesis: where, when and why?","volume":"107","author":"Morgan","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"2-3","key":"2026091519562313100_bnag010-B37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0161-5890(01)00044-X","article-title":"Extrahepatic synthesis of complement proteins in inflammation","volume":"38","author":"Laufer","year":"2001","journal-title":"Mol Immunol"},{"issue":"3","key":"2026091519562313100_bnag010-B38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2249.1998.00496.x","article-title":"Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas","volume":"111","author":"Andoh","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2026091519562313100_bnag010-B39","first-page":"290","article-title":"Complement gene expression in hepatic and extrahepatic tissues of NZB and NZB x W (F1) mouse strains","volume":"71","author":"Passwell","year":"1990","journal-title":"Immunology"},{"key":"2026091519562313100_bnag010-B40","volume-title":"Complement Regulatory Proteins","author":"Morgan","year":"1999"},{"issue":"14","key":"2026091519562313100_bnag010-B41","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"15","key":"2026091519562313100_bnag010-B42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"2026091519562313100_bnag010-B43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2014-1099","article-title":"Role of complement and complement regulatory proteins in the complications of diabetes","volume":"36","author":"Ghosh","year":"2015","journal-title":"Endocr Rev"},{"issue":"2","key":"2026091519562313100_bnag010-B44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1172\/JCI113637","article-title":"Complement induces a transient increase in membrane permeability in unlysed erythrocytes","volume":"82","author":"Halperin","year":"1988","journal-title":"J Clin Invest"},{"issue":"1","key":"2026091519562313100_bnag010-B45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood.V81.1.200.200","article-title":"Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9)","volume":"81","author":"Halperin","year":"1993","journal-title":"Blood"},{"issue":"6","key":"2026091519562313100_bnag010-B46","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF03401659","article-title":"The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes","volume":"2","author":"Acosta","year":"1996","journal-title":"Mol Med"},{"issue":"42","key":"2026091519562313100_bnag010-B47","doi-asserted-by":"crossref","first-page":"26424","DOI":"10.1016\/S0021-9258(18)47211-0","article-title":"Identity of a peptide domain of human C9 that is bound by the cell- surface complement inhibitor, CD59","volume":"269","author":"Chang","year":"1994","journal-title":"J Biol Chem"},{"issue":"1","key":"2026091519562313100_bnag010-B48","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41467-023-36441-z","article-title":"Structural basis for membrane attack complex inhibition by CD59","volume":"14","author":"Couves","year":"2023","journal-title":"Nat Commun"},{"issue":"19","key":"2026091519562313100_bnag010-B49","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1016\/S0021-9258(18)42266-1","article-title":"The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the \u201cb\u201ddomain of C9","volume":"267","author":"Ninomiya","year":"1992","journal-title":"J Biol Chem"},{"issue":"2","key":"2026091519562313100_bnag010-B50","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1073\/pnas.96.2.628","article-title":"Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting","volume":"96","author":"Sun","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2026091519562313100_bnag010-B51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1074-7613(03)00022-0","article-title":"Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility","volume":"18","author":"Qin","year":"2003","journal-title":"Immunity"},{"issue":"2","key":"2026091519562313100_bnag010-B52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ajh.21319","article-title":"Generation and phenotyping of mCd59a and mCd59b double-knockout mice","volume":"84","author":"Qin","year":"2009","journal-title":"Am J Hematol"},{"issue":"2","key":"2026091519562313100_bnag010-B53","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V98.2.442","article-title":"Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria","volume":"98","author":"Holt","year":"2001","journal-title":"Blood"},{"issue":"1","key":"2026091519562313100_bnag010-B54","first-page":"65","article-title":"Paroxysmal nocturnal hemoglobinuria. A complement-mediated disease","volume":"6","author":"Halperin","year":"1989","journal-title":"Complement Inflamm"},{"issue":"1","key":"2026091519562313100_bnag010-B55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood.V74.1.437.437","article-title":"The inab phenotype: characterization of the membrane protein and complement regulatory defect","volume":"74","author":"Telen","year":"1989","journal-title":"Blood"},{"issue":"17","key":"2026091519562313100_bnag010-B56","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJM199010253231707","article-title":"Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria","volume":"323","author":"Yamashina","year":"1990","journal-title":"N Engl J Med"},{"issue":"10","key":"2026091519562313100_bnag010-B57","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/eji.1830221029","article-title":"Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene","volume":"22","author":"Motoyama","year":"1992","journal-title":"Eur J Immunol"},{"issue":"1","key":"2026091519562313100_bnag010-B58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2012-07-441857","article-title":"CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy","volume":"121","author":"Nevo","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2026091519562313100_bnag010-B59","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejpn.2015.07.001","article-title":"Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency","volume":"19","author":"Ben-Zeev","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"10","key":"2026091519562313100_bnag010-B60","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1073\/pnas.97.10.5450","article-title":"Molecular basis for a link between complement and the vascular complications of diabetes","volume":"97","author":"Acosta","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2026091519562313100_bnag010-B61","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI111004","article-title":"Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease","volume":"72","author":"Falk","year":"1983","journal-title":"J Clin Invest"},{"issue":"2","key":"2026091519562313100_bnag010-B62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0272-6386(87)80089-6","article-title":"Ultrastructural localization of the membrane attack complex of complement in human renal tissues","volume":"9","author":"Falk","year":"1987","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"2026091519562313100_bnag010-B63","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.2337\/diabetes.51.12.3499","article-title":"Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy","volume":"51","author":"Zhang","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"2026091519562313100_bnag010-B64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/PL00007406","article-title":"Local activation of the complement system in endoneurial microvessels of diabetic neuropathy","volume":"99","author":"Rosoklija","year":"2000","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2026091519562313100_bnag010-B65","first-page":"1104","article-title":"Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy","volume":"43","author":"Gerl","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2026091519562313100_bnag010-B66","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","article-title":"Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes","volume":"53","author":"Qin","year":"2004","journal-title":"Diabetes"},{"issue":"4","key":"2026091519562313100_bnag010-B67","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc11-1642","article-title":"Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial","volume":"35","author":"Mellbin","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"2026091519562313100_bnag010-B68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrendo.2009.266","article-title":"Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily","volume":"6","author":"Flyvbjerg","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"2026091519562313100_bnag010-B69","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00125-010-1742-8","article-title":"Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes","volume":"53","author":"Hansen","year":"2010","journal-title":"Diabetologia"},{"issue":"5","key":"2026091519562313100_bnag010-B70","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2337\/diabetes.54.5.1523","article-title":"Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study","volume":"54","author":"Hovind","year":"2005","journal-title":"Diabetes"},{"issue":"2","key":"2026091519562313100_bnag010-B71","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2004.04.027","article-title":"Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation","volume":"44","author":"Uesugi","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2026091519562313100_bnag010-B72","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/db10-1181","article-title":"Transcriptome analysis of human diabetic kidney disease","volume":"60","author":"Woroniecka","year":"2011","journal-title":"Diabetes"},{"issue":"2","key":"2026091519562313100_bnag010-B73","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/diabetes.54.2.570","article-title":"Complement C3 is a risk factor for the development of diabetes: a population-based cohort study","volume":"54","author":"Engstrom","year":"2005","journal-title":"Diabetes"},{"issue":"7","key":"2026091519562313100_bnag010-B74","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2337\/dc13-2804","article-title":"Complement factor 3 is associated with insulin resistance and with incident type 2 diabetes over a 7-year follow-up period: the CODAM study","volume":"37","author":"Wlazlo","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"2026091519562313100_bnag010-B75","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/S0021-9258(19)85860-X","article-title":"Sites of nonenzymatic glycosylation of human hemoglobin A","volume":"255","author":"Shapiro","year":"1980","journal-title":"J Biol Chem"},{"issue":"29","key":"2026091519562313100_bnag010-B76","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1016\/S0021-9258(18)67052-8","article-title":"Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites","volume":"261","author":"Iberg","year":"1986","journal-title":"J Biol Chem"},{"issue":"3","key":"2026091519562313100_bnag010-B77","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1432-1033.1993.tb18067.x","article-title":"Site specificity of glycation of horse liver alcohol dehydrogenase in vitro","volume":"215","author":"Shilton","year":"1993","journal-title":"Eur J Biochem"},{"issue":"2","key":"2026091519562313100_bnag010-B78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(93)90165-Z","article-title":"The preferential site of non-enzymatic glycation of human apolipoprotein A-I in vivo","volume":"217","author":"Calvo","year":"1993","journal-title":"Clin Chim Acta"},{"key":"2026091519562313100_bnag010-B79","first-page":"186A","article-title":"Structural requirements for protein glycation","volume":"4","author":"Fl\u00fcckiger","year":"1995","journal-title":"Protein Sci"},{"issue":"3","key":"2026091519562313100_bnag010-B80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0969-2126(00)00020-4","article-title":"Structure of a soluble, glycosylated form of the human complement regulatory protein CD59","volume":"2","author":"Fletcher","year":"1994","journal-title":"Structure"},{"issue":"3","key":"2026091519562313100_bnag010-B81","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.185.3.507","article-title":"Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59","volume":"185","author":"Bodian","year":"1997","journal-title":"J Exp Med"},{"issue":"4","key":"2026091519562313100_bnag010-B82","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.185.4.745","article-title":"Mapping the active site of CD59","volume":"185","author":"Yu","year":"1997","journal-title":"J Exp Med"},{"issue":"4","key":"2026091519562313100_bnag010-B83","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-86-4-425","article-title":"Reversible hematologic sequelae of diabetes mellitus","volume":"86","author":"Peterson","year":"1977","journal-title":"Ann Intern Med"},{"key":"2026091519562313100_bnag010-B84","first-page":"748","volume-title":"Joslin's Diabetes Mellitus","author":"Bern","year":"1985"},{"issue":"3","key":"2026091519562313100_bnag010-B85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00283761","article-title":"Glycosylated haemoglobin and reticulocyte count in diabetes","volume":"22","author":"Giugliano","year":"1982","journal-title":"Diabetologia"},{"issue":"3","key":"2026091519562313100_bnag010-B86","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1042\/bj3160923","article-title":"Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis","volume":"316","author":"Meri","year":"1996","journal-title":"Biochem J"},{"issue":"9","key":"2026091519562313100_bnag010-B87","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.4049\/jimmunol.151.9.4941","article-title":"Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8","volume":"151","author":"Lehto","year":"1993","journal-title":"J Immunol"},{"issue":"5","key":"2026091519562313100_bnag010-B88","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/ki.1995.197","article-title":"Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis","volume":"47","author":"Lehto","year":"1995","journal-title":"Kidney Int"},{"issue":"4","key":"2026091519562313100_bnag010-B89","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1365-3083.2000.00783.x","article-title":"Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction","volume":"52","author":"Vakeva","year":"2000","journal-title":"Scand J Immunol"},{"issue":"8","key":"2026091519562313100_bnag010-B90","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ajh.23478","article-title":"A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes","volume":"88","author":"Ghosh","year":"2013","journal-title":"Am J Hematol"},{"issue":"13","key":"2026091519562313100_bnag010-B91","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.3390\/jcm14134588","article-title":"The relationship of the plasma glycated CD59 level with microvascular complications in diabetic patients and its evaluation as a predictive marker","volume":"14","author":"Yilmaz","year":"2025","journal-title":"J Clin Med"},{"issue":"10110","key":"2026091519562313100_bnag010-B92","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"2026091519562313100_bnag010-B93","doi-asserted-by":"crossref","first-page":"e4311","DOI":"10.1210\/clinem\/dgac498","article-title":"The role of early pregnancy maternal pGCD59 levels in predicting neonatal hypoglycemia-subanalysis of the DALI study","volume":"107","author":"Bogdanet","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091519562313100_bnag010-B94","doi-asserted-by":"crossref","first-page":"1374253","DOI":"10.3389\/fendo.2024.1374253","article-title":"Glycated CD59 is a potential biomarker for gestational diabetes mellitus","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2026091519562313100_bnag010-B95","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"issue":"7","key":"2026091519562313100_bnag010-B96","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.placenta.2010.03.010","article-title":"Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications","volume":"31","author":"Lynch","year":"2010","journal-title":"Placenta"},{"issue":"3","key":"2026091519562313100_bnag010-B97","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"issue":"6","key":"2026091519562313100_bnag010-B98","doi-asserted-by":"crossref","first-page":"e70013","DOI":"10.1002\/edm2.70013","article-title":"Plasma glycated CD59 and gestational diabetes mellitus: a systematic review","volume":"7","author":"Asadi","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"issue":"7","key":"2026091519562313100_bnag010-B99","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2337\/dc16-2598","article-title":"Plasma glycated CD59, a novel biomarker for detection of pregnancy-induced glucose intolerance","volume":"40","author":"Ghosh","year":"2017","journal-title":"Diabetes Care"},{"issue":"13","key":"2026091519562313100_bnag010-B100","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.3390\/jcm11133895","article-title":"The diagnostic accuracy of second trimester plasma glycated CD59 (pGCD59) to identify women with gestational diabetes Mellitus based on the 75 g OGTT using the WHO criteria: a prospective study of non-diabetic pregnant women in Ireland","volume":"11","author":"Bogdanet","year":"2022","journal-title":"J Clin Med"},{"issue":"9","key":"2026091519562313100_bnag010-B101","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/dc06-2361","article-title":"Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia","volume":"30","author":"Hillier","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"2026091519562313100_bnag010-B102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0301-2115(02)00480-3","article-title":"Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications","volume":"109","author":"Bartha","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"2026091519562313100_bnag010-B103","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.0001-6349.2005.00634.x","article-title":"Period of gestational diabetes mellitus diagnosis and maternal and fetal morbidity","volume":"84","author":"Barahona","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2026091519562313100_bnag010-B104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/dc15-0433","article-title":"Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment","volume":"39","author":"Sweeting","year":"2016","journal-title":"Diabetes Care"},{"issue":"5","key":"2026091519562313100_bnag010-B105","first-page":"1012","article-title":"Diabetes in pregnancy: a new decade of challenges ahead","volume":"61","author":"Schaefer-Graf","year":"2018","journal-title":"Diabetologia"},{"issue":"4","key":"2026091519562313100_bnag010-B106","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/0002-9378(93)90019-F","article-title":"Reproducibility of the oral glucose tolerance test in pregnant women","volume":"169","author":"Catalano","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2026091519562313100_bnag010-B107","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.0001-6349.2005.00650.x","article-title":"Gestational diabetes: a reappraisal of HBA1c as a screening test","volume":"84","author":"Agarwal","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"2026091519562313100_bnag010-B108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0028-2243(91)90295-V","article-title":"Serum fructosamine is not a useful screening test for gestational diabetes","volume":"38","author":"Corcoy","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2026091519562313100_bnag010-B109","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2393-13-142","article-title":"DALI: vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial - study protocol","volume":"13","author":"Jelsma","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"2026091519562313100_bnag010-B110","first-page":"903","article-title":"Effect of physical activity and\/or healthy eating on GDM risk: the DALI lifestyle study","volume":"102","author":"Simmons","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026091519562313100_bnag010-B111","doi-asserted-by":"crossref","first-page":"e1033","DOI":"10.1210\/clinem\/dgaa087","article-title":"Plasma glycated CD59 predicts early gestational diabetes and large for gestational age newborns","volume":"105","author":"Ma","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026091519562313100_bnag010-B112","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EJE-21-0635","article-title":"Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes","volume":"185","author":"Benhalima","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2026091519562313100_bnag010-B113","doi-asserted-by":"crossref","first-page":"110023","DOI":"10.1016\/j.diabres.2022.110023","article-title":"The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: a prospective study of non-diabetic pregnant women in Ireland","volume":"190","author":"Bogdanet","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"2 Pt 1","key":"2026091519562313100_bnag010-B114","first-page":"406","article-title":"Practice bulletin no. 137: gestational diabetes mellitus","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2026091519562313100_bnag010-B115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2393-14-226","article-title":"The Belgian diabetes in pregnancy study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design","volume":"14","author":"Benhalima","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9","key":"2026091519562313100_bnag010-B116","doi-asserted-by":"crossref","first-page":"e15121","DOI":"10.1111\/dme.15121","article-title":"The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: a prospective study of women diagnosed with GDM during a period of universal GDM screening","volume":"40","author":"Bogdanet","year":"2023","journal-title":"Diabet Med"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnag010\/68130067\/bnag010.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/47\/5\/565\/68130067\/bnag010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/47\/5\/565\/68130067\/bnag010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:56:44Z","timestamp":1789516604000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/47\/5\/565\/8660315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":116,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,4,21]]},"published-print":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnag010","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,4,21]]}}}